Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aclaris Therapeutics (ACRS) Long-Term Debt Repayments (2018)

Aclaris Therapeutics (ACRS) has 1 years of Long-Term Debt Repayments data on record, last reported at $149000.0 in Q4 2018.

  • For Q4 2018, Long-Term Debt Repayments changed N/A year-over-year to $149000.0; the TTM value through Dec 2021 reached $612000.0, changed N/A, while the annual FY2021 figure was -$11.5 million, N/A changed from the prior year.
  • Long-Term Debt Repayments reached $149000.0 in Q4 2018 per ACRS's latest filing, down from $164000.0 in the prior quarter.
  • Across five years, Long-Term Debt Repayments topped out at $299000.0 in Q2 2018 and bottomed at $36000.0 in Q1 2018.